AMNEAL PHARMACEUTICALS INC (AMRX) Stock News

NASDAQ:AMRX - Nasdaq - US03168L1052 - Common Stock - Currency: USD

8.24 -0.02 (-0.24%)

After market: 8.24 0 (0%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

AMRX Latest News, Press Relases and Analysis

All

Press Releases

6 days ago - By: Yahoo Finance

Amneal Pharmaceuticals (AMRX) Announces FDA Approval of Prednisolone Acetate Ophthalmic Suspension

9 days ago - By: Amneal Pharmaceuticals LLC

Amneal to Report Second Quarter 2025 Results on August 5, 2025

9 days ago - By: Amneal Pharmaceuticals LLC

Amneal to Report Second Quarter 2025 Results on August 5, 2025

2 months ago - By: Zacks Investment Research

3 Reasons Growth Investors Will Love Amneal (AMRX)

2 months ago - By: Zacks Investment Research

Here is Why Growth Investors Should Buy Amneal (AMRX) Now

23 days ago - By: Amneal Pharmaceuticals LLC

Amneal Highlights Positive Topline Results from Confirmatory Clinical Study of Biosimilar Candidate to XOLAIR(R) (omalizumab), Developed by Kashiv BioSciences

23 days ago - By: Amneal Pharmaceuticals LLC

Amneal Highlights Positive Topline Results from Confirmatory Clinical Study of Biosimilar Candidate to XOLAIR(R) (omalizumab), Developed by Kashiv BioSciences

a month ago - By: Amneal Pharmaceuticals LLC

Amneal Receives U.S. FDA Approval for Prednisolone Acetate Ophthalmic Suspension

a month ago - By: Amneal Pharmaceuticals LLC

Amneal Receives U.S. FDA Approval for Prednisolone Acetate Ophthalmic Suspension

2 months ago - By: Zacks Investment Research

Are Options Traders Betting on a Big Move in Amneal Pharmaceuticals Stock?

3 months ago - By: Benzinga

Examining the Future: Amneal Pharmaceuticals's Earnings Outlook

a month ago - By: Benzinga - Mentions: TEVA VTRS GS

Goldman Sachs Bullish On Branded Drug Upside At Teva: What About Viatris?

2 months ago - By: Amneal Pharmaceuticals LLC

Amneal to Participate at Upcoming Investor Conferences in June

2 months ago - By: Amneal Pharmaceuticals LLC

Amneal to Participate at Upcoming Investor Conferences in June

2 months ago - By: Amneal Pharmaceuticals LLC

Amneal Receives U.S. FDA Approval for Brekiya® (dihydroergotamine mesylate) injection for the Acute Treatment of Migraine and Cluster Headaches in Adults

2 months ago - By: Amneal Pharmaceuticals LLC

Amneal Receives U.S. FDA Approval for Brekiya® (dihydroergotamine mesylate) injection for the Acute Treatment of Migraine and Cluster Headaches in Adults

2 months ago - By: Zacks Investment Research

Does Amneal (AMRX) Have the Potential to Rally 54.16% as Wall Street Analysts Expect?

2 months ago - By: Amneal Pharmaceuticals LLC

Amneal and Apiject to Expand Sterile and Blow-Fill-Seal (BFS) Capabilities for Advanced Pharmaceutical Manufacturing in the U.S.

3 months ago - By: Zacks Investment Research

Amneal (AMRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

3 months ago - By: Zacks Investment Research - Mentions: VRCA

Amneal Pharmaceuticals (AMRX) Q1 Earnings Beat Estimates

3 months ago - By: Amneal Pharmaceuticals, Inc.

Amneal Reports First Quarter 2025 Financial Results

3 months ago - By: Yahoo Finance

Is Amneal Pharmaceuticals, Inc. (AMRX) the Best Pharma Stock to Buy for Long Term Growth?

3 months ago - By: Amneal Pharmaceuticals, Inc.

Amneal Donates $1.5 Million to Support Patients During Parkinson’s Awareness Month